HomeINVO • NASDAQ
add
Invo Bioscience Inc
Previous close
$0.98
Day range
$0.91 - $1.09
Year range
$0.50 - $10.50
Market cap
2.69M USD
Avg Volume
8.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.38M | 396.78% |
Operating expense | 2.00M | -27.46% |
Net income | -1.99M | 27.91% |
Net profit margin | -144.37 | 85.49% |
Earnings per share | — | — |
EBITDA | -1.37M | 49.34% |
Effective tax rate | -1.17% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 232.42K | 157.86% |
Total assets | 20.89M | 409.00% |
Total liabilities | 19.99M | 293.50% |
Total equity | 892.82K | — |
Shares outstanding | 2.74M | — |
Price to book | -0.48 | — |
Return on assets | -18.69% | — |
Return on capital | -40.22% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.99M | 27.91% |
Cash from operations | -714.88K | 28.81% |
Cash from investing | 33.29K | 287.86% |
Cash from financing | -141.53K | -117.69% |
Net change in cash | -823.12K | -320.90% |
Free cash flow | 2.57M | 2,798.98% |
About
Founded
2007
Headquarters
Website
Employees
28